Proteomics: Progress and Promise of High-Throughput Proteomics in Chronic Kidney Disease
Molecular & Cellular Proteomics · 2023
DOI: 10.1016/j.mcpro.2023.100550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2023. Verfasst von Pascal Schlosser und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Electronic address: pschlos3@jhu.edu. Hauptthemen laut MEDLINE: Proteome, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NINR NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Electronic address: pschlos3@jhu.edu.
- Division of Precision Medicine, Department of Medicine, New York University, New York, New York, USA.
- Nephrology Division and Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NINR NIH HHS
- Deutsche Forschungsgemeinschaft
- NIH
Zitieren
APA
Schlosser, P., Grams, M. E., & Rhee, E. P. (2023). Proteomics: Progress and Promise of High-Throughput Proteomics in Chronic Kidney Disease. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2023.100550
Vancouver
Schlosser P, Grams ME, Rhee EP. Proteomics: Progress and Promise of High-Throughput Proteomics in Chronic Kidney Disease. Molecular & Cellular Proteomics. 2023. doi:10.1016/j.mcpro.2023.100550
BibTeX
@article{Schlosser2023,
author = {Schlosser, Pascal and Grams, Morgan E and Rhee, Eugene P},
title = {Proteomics: Progress and Promise of High-Throughput Proteomics in Chronic Kidney Disease},
journal = {Molecular & Cellular Proteomics},
year = {2023},
doi = {10.1016/j.mcpro.2023.100550}
}
EUVIMED